NCT00046397View on ClinicalTrials.gov

Phase I Trial of Smallpox Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2005

Conditions
Healthy
Interventions
DRUG

Modified Vaccinia Virus Ankara TBC-M

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00046397 - Phase I Trial of Smallpox Vaccine | Biotech Hunter | Biotech Hunter